Unknown NA INTERVENTIONAL 2-arm NCT02644915

Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation Patients (I/R)

Effect of Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation Patients: A Single-Center, Double-Blinded, Randomised Controlled Trial

Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Conditions Kidney Transplantation

Interventions 0.9%%NaCl solution Edaravone

Updated 7 times since 2017 Last updated: Dec 30, 2015 Started: Mar 31, 2016 Primary completion: Sep 30, 2016 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Kidney Transplantation, this trial is ongoing. The trial is conducted by First Affiliated Hospital Xi'an Jiaotong University and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Feb 2018 — Jun 2018 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status

▶ Show 2 earlier versions

Feb 2017 — Feb 2018 [monthly]

Not Yet Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting NA

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

First Affiliated Hospital Xi'an Jiaotong University
Xijing Hospital

Data source: Xijing Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.